Literature DB >> 11448724

Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow.

M Van de Casteele1, H Sägesser, H Zimmermann, J Reichen.   

Abstract

Several portal hypertensive animal models are available and frequently used for haemodynamic studies. The portal venous inflows, measured with microspheres in pentobarbital anaesthetised rats, are compared here. The partial portal vein ligation model is characterised by a high portal venous inflow, together with extensive portal systemic shunting, at the cost of portal sinusoidal flow. In carbon tetrachloride-induced micronodular cirrhosis, portal sinusoidal flow, which reaches liver parenchyma, is high, and this is more pronounced in the presence of ascites. In bile duct ligation and excision-induced cirrhosis, an increase in liver weight was not equally followed by an increase in portal sinusoidal flow, pointing to a relatively underperfused liver.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448724     DOI: 10.1016/s0163-7258(01)00123-1

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  8 in total

1.  Sodium Ferulate Reduces Portal Pressure Through Inhibition of RhoA/Rho-Kinase and Activation of Endothelial Nitric Oxide Synthase in Cirrhotic Rats.

Authors:  Jiqiao Liu; Liping Peng; Juan Yang; Min Wang; Shengnan Xu; Jingmei Liu; Ping Han; Jiayi He; Dean Tian; Qi Zhou
Journal:  Dig Dis Sci       Date:  2015-02-28       Impact factor: 3.199

2.  Morphological and biomechanical remodelling of the hepatic artery in a swine model of portal hypertension.

Authors:  Xi-Ju He; Ming-Hua Yu; Wen-Chun Li; Han-Qin Wang; Jing Li; Xing-Chun Peng; Jie Tang; Na Feng; Tie-Zhu Huang
Journal:  Hepatol Int       Date:  2011-09-23       Impact factor: 6.047

3.  Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.

Authors:  Q Zhou; M Hennenberg; J Trebicka; K Jochem; L Leifeld; E Biecker; T Sauerbruch; J Heller
Journal:  Gut       Date:  2006-02-21       Impact factor: 23.059

4.  Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation.

Authors:  Anja M Geerts; Eline Vanheule; Marleen Praet; Hans Van Vlierberghe; Martine De Vos; Isabelle Colle
Journal:  Int J Exp Pathol       Date:  2008-08       Impact factor: 1.925

5.  Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis.

Authors:  M Hennenberg; J Trebicka; C Stark; A Z Kohistani; J Heller; T Sauerbruch
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

6.  Differential Sympathetic Vasomotor Activation Induced by Liver Cirrhosis in Rats.

Authors:  Heder F G Estrela; Elaine S Damásio; Eduardo K U N Fonseca; Cássia T Bergamaschi; Ruy R Campos
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

7.  Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension.

Authors:  Frank E Uschner; Ganesh Ranabhat; Steve S Choi; Michaela Granzow; Sabine Klein; Robert Schierwagen; Esther Raskopf; Sebastian Gautsch; Peter F M van der Ven; Dieter O Fürst; Christian P Strassburg; Tilman Sauerbruch; Anna Mae Diehl; Jonel Trebicka
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

8.  Establishment of a reversible model of prehepatic portal hypertension in rats.

Authors:  Xin Zhao; Jian Dou; Qing-Jun Gao
Journal:  Exp Ther Med       Date:  2016-05-30       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.